Identify where your life science business is quietly losing €250k–€10m per year — before it shows up in your runway, valuation, or deal terms.
Most Life Science Companies Don’t Fail on Science
They fail on unseen cost leakage:
- R&D programs that should have been stopped earlier
- CMC and manufacturing decisions that inflate COGS long-term
- Regulatory rework caused by late or fragmented strategy
- Commercial blind spots that destroy value at launch
- Consultant and external spend with unclear ROI
These costs accumulate silently — often until investors, partners, or acquirers expose them.
The Life Science Cost Leakage Audit™
The Life Science Cost Leakage Audit™ is a structured, executive-level diagnostic designed for:
- Biotech and medtech SMEs
- CDMOs and platform technology companies
- University spin-outs and scale-ups
It helps you identify, quantify, and prioritise hidden cost risks across your entire value chain — in under 60 minutes.
This is not a financial audit.
It is a strategic cost–value diagnostic.
What the Audit Covers
The audit assesses 6 critical cost leakage domains:
- R&D Strategy & Portfolio Focus
Are resources aligned with commercial value — or scientific inertia? - CMC, Manufacturing & Supply Chain
Are today’s decisions quietly inflating tomorrow’s COGS? - Regulatory & Quality Strategy
Are you paying for rework, delays, and avoidable complexity? - Commercial Readiness & Market Access
Is value being destroyed before the product reaches patients? - Organisational Design & External Spend
Are structure and consultants creating drag rather than momentum? - Data, Digital & Decision Infrastructure
Are decisions supported by insight — or hindsight?
What You Receive
When you download the Life Science Cost Leakage Audit™, you receive:
- A 30-question structured diagnostic across the full value chain
- A clear scoring and interpretation framework
- Indicative cost exposure ranges (€) linked to your risk profile
- Anonymised real-world mini-cases from life science organisations
- A clear view of where to look next — and where not to waste time
Most organisations complete the audit in 45–60 minutes.
What Your Score Really Means
Score Range | Risk Level |
Indicative Annual Cost Exposure |
0–40 | Severe | €2m – €10m+ |
41–70 | High | €1m – €5m |
71–95 | Moderate | €250k – €1m |
96–120 | Low | < €250k |
The numbers are conservative — and they add up faster than most leadership teams expect.
Who This Audit Is For
This audit is designed for:
- CEOs, COOs, and Founders
- CFOs and Heads of Operations
- Strategy, Portfolio, and Commercial Leaders
It is most valuable for organisations that are: – Preparing for scale-up or funding – Managing multiple programs or assets – Approaching licensing, partnering, or M&A
Who This Audit Is Not For
- Companies seeking tactical fixes or templates
- Organisations outsourcing thinking
- Teams unwilling to act on uncomfortable insights
This audit surfaces where value is leaking — not how to cosmetically mask it.
Optional: Executive Cost Leakage Review
Many organisations choose to review their results with i3 Consult to:
- Translate scores into quantified cost exposure
- Prioritise corrective actions across functions
- Assess impact on runway, valuation, or deal readiness
Optional 60-minute confidential review
Available after completing the audit.
To set up this review meeting, please click here to fill out a contact form and one of our representatives will arrange that meeting at a time of your convenience.
Download the Life Science Cost Leakage Audit™
Price: €199 (PDF download)
Gain clarity on where your organisation is quietly losing value — and where decisive action will have the greatest impact.
About i3 Consult
Founded in 2002, i3 Consult works with life science organisations to identify and correct structural cost–value misalignment across the product lifecycle.